Real-time enrollment status for this breast cancer clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 5:32 PM UTC
| NCT Number | NCT06993844 |
| Recruiting Status | Recruiting |
| Condition | Breast Cancer |
| Phase | PHASE1 |
| Target Enrollment | 233 participants |
| Active Locations | 10 sites in the US |
| Sponsor | Ensem Therapeutics |
| Last Updated on CT.gov | June 23, 2026 (3 weeks ago) |
As of July 17, 2026: Clinical trial NCT06993844 is currently recruiting participants. This phase1 study for breast cancer is actively seeking new participants at 10 locations across the United States. The study is sponsored by Ensem Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06993844 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 10 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06993844 was last updated 3 weeks ago (June 23, 2026). HelloStudys verifies this status automatically.